Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

Nationally Noted UC San Diego Allergist Elected ABAI President, 2010

 

September 02, 2008  |  

Stephen I. Wasserman, M.D., to Serve as President-Elect

The American Board of Allergy and Immunology (ABAI) announced that it has elected Stephen I. Wasserman, M.D., professor of medicine, UC San Diego School of Medicine and Director, Allergy/Immunology section, as the organization’s president-elect.  Dr. Wasserman will assume his duties as President on January, 1, 2010. 

ABAI is the entity that oversees the certification of physicians specializing in Allergy and Immunology.

As a teacher, researcher and physician, Wasserman has devoted more than 30 years of his career to the specialty of allergy and immunology.  Wasserman has worked at the University of California, San Diego since 1979, where he founded the Allergy and Immunology training program within the Department of Medicine.  From 2000 to the present, he has been listed in America’s “Top Doctors.”  Wasserman has received numerous grants for asthma research, in addition to writing and co-writing over 200 articles and book chapters.

Wasserman is also a featured doctor on the ABCNews.com “OnCallPlus” special section on asthma.  He answered various questions regarding topics such as the standard treatment of asthma, steroid use in controlling asthma, and the latest research being conducted at UC San Diego School of Medicine. 

Wasserman is a member of several professional societies including ABAI where he served as Chairman, the American Academy of Allergy, Asthma, and Immunology, where he served as president from 1998 – 1999, and the American Board of Medical Specialties, where he currently serves as Secretary/ Treasurer.  He is also certified by the American Board of Allergy and Immunology where he was elected as a Director, Secretary, Examination co-chair and served as Chairman. 

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu




Media Contact

Share This Article


Related News

8/5/2020
Researchers at UC San Diego School of Medicine report successfully implanting specialized grafts of neural stem cells directly into spinal cord injuries in mice, then documenting how the grafts grew a ...
8/5/2020
The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthe ...
8/4/2020
Researchers at University of California San Diego School of Medicine report that sleep may help people to learn continuously through their lifetime by encoding new memories and protecting old ones.
8/3/2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live ...



Follow Us